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Modulation of Inflammatory 
Dynamics by Insulin to Promote 
Wound Recovery of Diabetic 
Ulcers
Pawandeep Kaur and Diptiman Choudhury
Abstract
About 5% of the world population is diabetic and are at a risk of slow non-
recoverable wound formation. Estimated 15–25% of diabetic patients develop foot 
ulcers, 6% among them needing clinical attention among which 15–20% will need 
an amputation. This counts for around 50% of all traumatic amputation. Wound 
leads to activation of dynamic inflammatory cascade responsible for the healing 
process. But in diabetes, a persistent rise of pro-inflammatory cytokines and low 
anti-inflammatory cytokines blocks the dynamic cascade. Wounding induces vari-
ous pro-inflammatory cytokines such as IL-1, IL-6, IL-12, IL-18, IFN-γ, and TNFs 
causing accumulation of free radicals leading to inflammation which become per-
sistent in diabetes. Inhibition of proinflammatory cytokines drives the equilibrium 
towards the expression of anti-inflammatory cytokines such as IL4, IL-10, IL-11, 
IL-13, IFN-α, and TGF-β, which is necessary for the wound recovery process. Here 
in this chapter, the inflammatory modulatory roles of different drugs/formulations 
have been discussed to unravel their significance to promote wound recovery.
Keywords: diabetic wound, tissue inflammation, pro-inflammatory cytokines, anti-
inflammatory cytokines, nanoformulation for wound recovery
1. Introduction
Over the last 25 years, there has been found a four-fold increase in the number of 
diabetes mellitus cases commonly called diabetes [1]. 422 million people worldwide 
in 2016 have been reported to have diabetes mellitus. Diabetes in the year 2012 
was a cause of 1.5 million deaths worldwide; according to WHO (World Health 
Organization), diabetes becomes the 8th leading cause of death [2]. Diabetes melli-
tus is mainly identified by the presence free glucose at high or the chronic level in the 
body fluids like sweat, urine, blood, etc. [3]. The major reason for diabetes mellitus 
among others was the hormone-mediated metabolism regulation failure. Hormones 
like glucagon and insulin play an important role in regulating the level of blood sugar 
or maintaining its balance [4]. The sugar balance in blood is important for perfect 
functioning of human body [5]. High/chronic level of glucose in body fluids is 
responsible for different pathological conditions like infection susceptibility, leading 
to various diseases such as arthritis, hypertension, cardiovascular problems, cataract, 
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retinopathy, neuropathy, damage of kidneys, damaging of blood vesicles, wound 
healing delay, etc. (Figure 1) [5, 6]. Due to the linkage of diabetes mellitus with other 
different diseases, the International Diabetes Foundation (IDF), in 2014, recorded 
that the 4.9 million lives loss and ~1.25% dead were diabetic patients, either directly 
by diabetes mellitus or indirectly through other diseases [7]. All these diseases are 
linked causing various effects on different body organs with various pathways; 
pathological/hyperglycemic conditions are linked with the inflammation of tissue 
[8]. Diabetes is responsible for lower gradation inflammation in a systemic way and 
leads to the promotion of different diseases like arthritis, retinopathy, etc. [9, 10].
One of the major problems associated with diabetes mellitus is inflammation in 
wounds and results in wound recovery delay [11]. The chronic wounds in diabetes 
mainly show the persistent increase in the level of pro-inflammatory cytokine 
and the absence of the signals, which are responsible for signals in the damaged 
tissues [12]. The treatments used in diabetes mellitus are also helpful in control-
ling the level of glucose blood and helps in delaying the further progression of 
other diseases linked with diabetes mellitus, like retinopathy, contract, arthritis, 
neuropathy, retinopathy, etc., but very less is known in the literature about diabetes 
mellitus treatment’s effects on diabetic wound recovery [13]. Wound results in 
release of the pro-inflammatory cytokines such as interleukin-6 (IL-6), IL-1, IL-12, 
IL-18, and tumor necrosis factors (TNFs) and interferon-gamma (IFN-γ), which 
results in inflammation of tissues [14]. Pro-inflammatory cytokines like IL-6 and 
IL-1β are released from the macrophages and monocytes in the wound and result 
in pain responses by signaling the neurons [15]. IFN-γ, IL-1β, and TNF-α induce 
apoptosis and pyroptosis mediated by the activation of innate immunity and 
oxidative stress [16]. IFN-γ is an activator; it activates macrophages by stimulating 
STAT1 expression in order to activate the defense mechanism against the pathogens 
in the infected area [17]. IL-12 stimulates TNF-α and IFN-γ production and reduces 
the expression of IL-4, an anti-inflammatory cytokine, and negatively controls the 
expression of IFN-γ; IL-4 also through the activation of STAT-3 signaling inhibits 
IFN- γ [18]. IL-18 for defense against pathogens activates T cells and natural killer 
Figure 1. 
M1 macrophages (also known as classically activated), such as IL-12, IL-1β, IL-10, STAT1, TNF-α, and 
NFkβP50/P65, are leads to wound inflammation. Alternatively, active, that is, M2 macrophages, such as 
STAT3, HIF-α, PKC, NFkβP50/P50, etc., help in healing of the wound by decreasing inflammation. People 
having diabetes show prolonged M1 macrophage expression in wounds in comparison to nondiabetic wounds 
that delay M1 to M2 macrophage transition.
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(NK) cells and promotes the expression of of IFN-γ cytokines at the wound site 
[19]. However, the prolonged expression of inflammatory cytokines leads the dam-
age of tissues, which results in a delay in the repairing process of wounds. IL-1 is a 
TNF activator and is responsible for the damaging of cells. IL-1β overproduction is 
responsible for neuronal tissue inflammation, leads to damage of neuro-muscular 
junctions and ultimately leads to delaying in wound healing [20]. In the presence of 
pathogens, the macrophages secrete IL-6 which in turn increases Toll like receptor 
expression (TLR)-9 response-mediated defense for killing foreign particles. In 
case of prokaryotes, unmethylated DNA activates the TLR-9 pathway and helps 
in killing the pathogen at the wound site; mitochondrial DNA spillage, essentially 
the unmethylated DNA, triggers similar kind of responses in the tissue of wound 
[21]. In tissues, the angiogenesis is inhibited by IL-12 by overexpression of IFN-γ-
mediated interferon-gamma-induced protein 10 (CXCL-10 or IP-10) [22]. Vascular 
endothelial growth factor (VEGF) expression is negatively controlled by IL-18, 
essential for the development of new blood vessels at the wound site and is essential 
for the growth and repair at wound tissue [23].
To start and control the wound healing mechanism, the inflammation is most 
important. In the nondiabetic wounds, anti-inflammatory cytokines like IL-4, IL-10, 
IL-13, IL-11, and transforming growth factor-beta (TGF-β) and interferon-alpha 
(IFN-α) play an important role in the wound healing process [24]. At the initial 
stage of wound recovery, TLR-9 induces the instant expression of pro-inflammatory 
signals like TNF-α through the increase in expression of mitogen-activated protein 
kinase (MAPK)/p38 and c-Jun N-terminal kinase (JNK) pathway [25]. In non-
diabetic wounds, MAPK activation is prolonged and leads to MAPK phosphatase 
enzyme activation, which works as a negative regulator of JNK and MAPK/p38 path-
ways, resulting in the negative regulation of TNF-α production. The de-phosphory-
lation of MAPK/p38 leads to more expression of anti-inflammatory cytokines such as 
IL-10 a homodimeric cytokine, which is produced by the macrophages, monocytes 
and induce signaling of TGF-β, and can enhance the division of cells [26]. Cytokines 
like IL-4, IL-13, and IL-10 can stimulate extracellular matrix and fibrinogen, mainly 
collagen synthesis. IL-4, cytokines secreted by macrophages, mast cells and inflamed 
T cells activate the Janus kinase/signal transducer and transcription-6 (Jak/STAT6) 
pathway activator which promotes the wound repairing [27]. IL-4 is responsible for 
the extracellular matrix synthesis, mainly collagen which gives the physical sup-
port for the healing of the wound [28]. Another kind of cytokine, L-1RA, secreted 
from immune cells, adipocytes cells and cells of epithelia, leads the inhibition of 
pro-inflammatory IL1β cytokine effect by binding with the (IL-1R) interleukin-1 
receptor. On the other hand, deregulation of TNF-α and IL-1β prolongs the phase of 
inflammation phase and leads to delay in wound healing [29]. IL-11 released from 
cells of bone marrow expresses anti-inflammatory effect. IL-11 inhibits the synthesis 
of IL-1 and TNF-α synthesis by the inhibition of NFkβP50/P65 with increasing the 
expression of inhibitory NFkβP50/P50 synthesis in monocytes/macrophage cells 
[30]. Transition between cytokines of pro and anti-inflammatory is balanced in 
nondiabetic wounds but in case of diabetic wounds, it gets impaired (Figure 1).
For the type-1 diabetes treatment or insulin-dependent diabetes, insulin is 
administrated systematically.
2.  Activation of anti-inflammatory cytokines and increased 
differentiation of cells by signaling through insulin
Insulin, released from pancreatic gland produced in its beta cells of the islets 
of Langerhans is a peptide hormone. Insulin precursor is proinsulin in humans, is 
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encoded by the INS gene and is a single polypeptide; after processing of proinsulin, 
two secretory proteins are produced, one chain having two chains namely A (21 
amino acids) and B (30 amino acids), which forms mature insulin, and the second is 
C-chain known as C-peptide having 31 amino acids [31, 32]. Chain “A” is more com-
pact having (2 small) α-helix region; on other hand, B chain has 1 such region. Two 
disulfide bonds between A20-B19 and A7-B7 hold chain A and chain B together; in 
addition to this, there is a disulfide bridge between A7-A11 cys amino acids of chain 
A. In the presence of Zn2+ and at ~6.0 favorable insulin pH, it folds to hexameric 
forms and is stored in pancreas. After diffusion of insulin in blood, with change in 
the pH, the hexameric insulin form changes to its monomeric form and shows bind-
ing with the insulin receptor [33]. The insulin binding with receptors depends on 
the regions present in the insulin monomeric form. The binding regions are present 
on the surface of insulin receptors; the changes or mutations in the binding regions 
reduce the insulin binding affinity [34]. The regions are located at TyrA19, AsnA21, 
CysA20, on the “A” chain C-terminus, IleA2, GlyA1, GluA4, ValA3, on the N terminus 
and at PheB24, GlyB23, TyrB26, and PheB25 at B” chain C-terminus (Figure 2) [35].
The insulin is found only in the humans, but peptides which are like insulin are 
also present in invertebrates like insects and molasses. Insulin-like peptides are hav-
ing growth-related functions, and it indicates that the insulin is not only involved 
in metabolism of glucose but has other functions as well [37]. Drugs which can 
balance between the pro-inflammatory and anti-inflammatory cytokines can also 
be helpful for the treatment of other insulin-independent or dependent diabetes 
mellitus and its linked disease conditions. Using insulin as a wound-healing agent, 
very few studies have been found.
The anti-inflammatory effect by insulin is shown by activating the cytokine 
expression that can decrease the inflammation and help in recovery of the wound. 
Through metabolism and synthesis activities, insulin shows its effect on the differ-
entiation and survival of cells. Insulin promotes NF-kβP50/P50 upregulation by the 
suppression of TNF-α and p65 expression. NF-kβP50/P65 expression suppression 
leads to decrease in expression of proinflammatory cytokines like IL-12, IL-1β, IL-6, 
and TNF-α cytokines at the site of wound [38]. Proinflammatory cytokine inhibi-
tion shifts the equilibrium towards the anti-inflammatory cytokine expression, like 
Figure 2. 
Insulin structure (a) showing the sequence of amino acids present in insulin protein (b) showing the 3-D model 
of insulin [36].
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IL-4, IL-10, and VEGF, etc., inhibits the apoptosis of cells, and increases prolifera-
tion of cell similarly like IGF [39]. Below sections show the regulation of cytokine 
dynamics by the insulin: (a) Inactivation of NFkβp50/p65 by insulin results in 
decrease in inflammation by inducing uptake of glucose uptake, (b) biosynthesis of 
fatty acid induction by insulin and inactivation through TNF-α, (c) role of insulin 
in cell differentiation and growth by synthesis of protein and inhibition of prote-
olysis by inactivation of FOXO to promote the survival of cell, (d) insulin functions 
like IGF and activates the same signaling pathway and reduces inflammation, and 
(e) anti-inflammatory action of insulin by reduction in proinflammatory cytokines 
and increased expression of the anti-inflammatory cytokines (Figure 3).
2.1 Role of insulin to promote wound recovery
2.1.1  Inactivation of NFkβp50/p65 by insulin results in decrease in inflammation 
by inducing uptake of glucose
The presence of high concentration of glucose at the wound site promotes 
microbial growth and leads to inflammatory signaling activation. The main func-
tion of insulin in the body is regulation of blood glucose level. It helps in the utiliza-
tion of the glucose present in the blood through activation of glucose transporters 
and stored in glycogen form in the cells. The glycogen stored in the tissue of muscles 
behaves as a source of energy and gets used aerobically [40]. Wounds mainly in 
peripheral nerves, renal cortex, and retina are results from microcirculatory dam-
age mainly due to increment in consumption of wound by the inflammatory cells, 
which leads to switch from aerobic glycolytic to anaerobic glycolytic [41]. The direct 
result of this is the lactic acid formation as the end glycolysis product. In addition to 
this, other resources of anaerobic glycolysis are the wound-proliferating cells, which 
are showing anaerobic respiration in the muscle cells [42]. In the blood, the lactic 
acid gets used in the liver to form glucose.
Lactate converts into pyruvate and nicotinamide adenine dinucleotide (NADH); 
NADH behaves as a substrate for nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase and helps in the formation of reactive species of oxygen (ROS) 
induced by lactate [43]. Due to more NADPH synthesis, NADPH to NAD+ ratio 
Figure 3. 
Insulin plays an important role as an anti-inflammatory agent and helps in the survival of cells by synthesis 
and metabolic pathways. Glucose metabolism activates NFk-β, and biosynthesis of fatty acids leads to TNF-ɑ 
activation which can inactivate the inflammatory signaling. By this signaling, insulin helps in the survival of 
cells and synthesis of protein. Along with this, the insulin activates the Akt pathway and can increase mTOR, 
MMPs, and eNOS expression leading to the formation of new blood vessels. Insulin can also decrease the 
NFkβP50/P65 expressions by the ERK and MEK pathways like the pathway for glucose uptake.
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reduces, which leads to the VEGF activation and angiogenesis. NADPH and pyru-
vate, both lead to the formation of new blood vessels and collagen through the 
inactivation of prolyl hydroxylase hypoxia inducible factor (HIF PHD) [44].
HIF causes the damage of tissue and inflammation at the wound [45]. Hypoxia is 
also responsible for the damage of peripheral blood vessels and also causes activates 
NADP oxidase (NOX) to generate oxidative stress in the wound, regulating key 
factor in the process of wound recovery and leading to inter-cellularly ROS over-
expression [46]. High ROS level induces oxidation of protein and peroxidation of 
lipid, which causes apoptosis of cells [47]. The production of ROS leads to accumu-
lation of NFkβP50/ P65 and inhibits HIF1 α and mTOR expression. In addition to 
mTOR and HIF1 inhibition, NFkβp50/NFkβp65 induces resistin expression, and 
both are responsible for intercellular insulin resistance [48]. The resistin leads to the 
activation of vicious cycle through p65 overexpression [49]. P65 activation shifts 
the equilibrium from NFκβp50/p50 to NFκβp50/p65 and results in insulin resistance 
generation [50]. It also induces mTOR and HIF1, by activation of the AKT path-
way and inhibition of TNFα [51]. HIF1 activation shifts back to NFκβp50/p65 to 
NFκβp50/p50 equilibrium. The blood glucose normalization is possible with insulin 
proper functioning and also by the effective reduction of NFkβP50/P65 expression 
[52]. NFkβP50/P50 activation reduces expression of proinflammatory cytokines 
like IL-6 and IL-1β, induces high anti-inflammatory cytokine expression, leads to 
reduction in inflammation stage, and enhances repairing of tissue [50].
Pyruvate and NADPH inactivate the expression of HIF PHDs, by the oxidation 
of ascorbic acid and Fe (II). HIF PHDs are the dioxygenase and are 2-oxoglutarate 
and Fe (II)-dependent and require ascorbic acid. In lactate presence, ascorbic acid 
and Fe (II) get oxidized and inhibit damage of tissue and increase IL-8release, 
basal fibroblast growth factor (bFGF) and NF-kβP50/P50 activation [53]. Lactate 
also upregulates the expression of NF-kβP50/P50 by suppressing the formation 
of NF-kβP50/P65 and results in reduction of expression of IL-12, IL-1β, TNF-α, 
and IL-6 cytokines. This pathway ultimately results in more cell viability. Also, 
ROS-dependent IkBɑ expression inhibition and VEGF receptors are responsible 
for synthesis of collagen and angiogenesis [54]. IkBɑ helps in NFkβ translocation 
from nucleus, and p65 gene expression in turn is responsible for inflammation [55]. 
Along with this, NF-kβP50/P65 expression suppression happens through the phos-
phorylation of ERK through signaling of insulin [56]. In contrast to these findings, 
the lactate formed in skeletal muscles impairs the signaling of insulin and results in 
glucose metabolism inhibition [57]. Glucose metabolism signaling of insulin occurs 
through 6-phosphofructo-1-kinase (PFK-1), which in turn is formed by pyruvate 
dehydrogenase (PDH) and fructose-2, 6-biphosphate and used for the conversion 
pyruvate to oxaloacetate. This signaling of insulin is inhibited by lactate through 
the production of more citrate and reducing fructose-2, 6-biphosphate, and inhibits 
and promotes PFK-1 expression, respectively. Inhibition of PDH by rising ratio of 
NADH to NAD ultimately stops the pyruvate to oxaloacetate transformation [58]. 
This negative effect of lactate on glucose metabolism shows that it acts as an glycol-
ysis inhibitor and results in increase in concentration of glucose in the blood serum 
[59]. The glucose high concentration in the blood leads to long-time expression of 
the inflammation cytokines at the wound site (Figure 4).
2.1.2  Fatty acid biosynthesis induction by insulin and inactivation through TNF-α 
pathway
Insulin also plays different other functions like it can stimulate the synthesis 
of protein and lipogenesis, as well as differentiation and growth of cells [60]. 
The lipogenesis is the fatty acid synthesis process which converts acetyl-CoA 
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to triglycerides [61]. Lipogenesis is stimulated by insulin through two types of 
enzyme activation, PDH (pyruvate dehydrogenase), responsible for pyruvate con-
version to acetyl CoA and another acetyl CoA carboxylase helps in conversion of 
acetyl to malonyl CoA. In the cytoplasm, Malonyl CoA gives 2-C building blocks, 
used for larger fatty acid synthesis [62]. Transportation of acetyl CoA from mito-
chondria to cytoplasm occurs by tricarboxylate translocase enzyme, after forma-
tion of citrate by reaction with oxaloacetate. The glucose shows a role in increasing 
the release of both citrate and insulin [63].
Fatty acids, mainly polyunsaturated, play an important role in the formation 
of cell membrane. Cell membrane composition affects the absorption of enzymes 
which are responsible for cell phosphatidylinositol 4-kinase (PI4K) proper func-
tioning; membrane associated phosphatidylinositol kinase shows an important role 
in signaling of cell [64]. The fat metabolism products activate PI4K, which in turn 
regulates the Protein Kinase C (PKC) functioning and controls proinflammatory 
cytokine TNF-ɑ signaling [65]. PKC also induces inflammation through increasing 
the NFkβ and p38MAPK expression. In PI4K presence, the activity of PKC is inhib-
ited, which leads to the reduction of proinflammatory cytokine (TNF-ɑ) release 
[66]. The free fatty acid component plays an important role in the wound recovery 
process (Figure 4).
Figure 4. 
Transition pathway from M1 to M2 macrophages. TNF ɑ and IFN ϒ activate NFk β, STAT1, and IRF-3 at 
the wound site and help in the release of IL-10, IL-12, NFkβP50/P65, TNF-α, IL-1β, and STAT-1 leading to 
inflammation. M1 to M2 transition is important for wound recovery. IL-10, IL-4, IL-13, VEGF, insulin, and 
IGF can activate HIF-α, STAT3, and NFkβP50/P50 cytokines to activate the anti-inflammatory action.
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2.1.3  Role of insulin in cell differentiation and growth by synthesis of protein and 
proteolysis inhibition by the inactivation of FOXO to enhance the survival of 
the cell and tissue
Insulin stimulates the synthesis of protein in different cells and tissues. In muscle 
tissues, insulin affects the flow of blood and amino acids uptake by the tissues of 
muscle and helps in anabolism in the muscles [67]. It has been studied that insulin 
systematic uptake loses the muscle volume, which mainly happens due to insulin 
systematic infusion and results in the reduction of the amount of free amino acids 
in blood and plays an important role in the anabolism in muscles [68]. The defi-
ciency of insulin can be overcome by systematically giving insulin exogenously [69]. 
Essential protein formation is stimulated by promoting the concentration of RNA 
contents in the cells and tissues by the insulin functioning pathway through the 
translocation of the mRNA by the phosphoinositide-3-kinase (PI3K) pathway [70]. 
By the PI3K pathway, an Akt inhibits the tuberous sclerosis protein ½ (TSC1/2) 
functioning and behaves like an inhibitor of the mechanistic target of rapamycin 
(mTOR) and in the end by phosphorylation of 4E Binding protein (4EBP-1leads 
it activates the eukaryotic initiation factor (eIF4B)). The eukaryotic 20 structured 
mRNA 5’end eIF4B binds. During the synthesis of protein, eIF4B binds with 
subunits of eIF4A and eIF4G, further binding with ribosome 40S, and it has RNA 
helicase absent or low results in impairment in the synthesis of protein. The mTOR 
activation leads to proteolysis inhibition by MAPox activation [71]. High concen-
tration of insulin in the muscle cells inhibits the protein degradation and leads to 
muscle cell and tissue expansion [72]. Due to inhibition of protein degradation, the 
insulin ultimately leads to reduce the blood amino acids concentration [73]. This 
amino acid concentration regulation of insulin clearly indicates that insulin plays a 
very important part in the diabetic wound healing condition when the patients are 
on systemic treatment of insulin (Figure 4).
2.1.4  Insulin behaves the same as insulin-like growth factor and can also activate 
similar pathway to decrease the inflammation
Insulin-like growth factor (IGF) is composed of two IGF ligands such as IGF-I 
and II. At the time of embryogenesis, IGF are the proteins that regulate develop-
ment and growth, tissue differentiation in adults and show anti-inflammatory 
actions through the activation of anti-inflammatory cytokines. Insulin shows anti-
inflammatory effect by increasing release of IL-10 and IL-13/4. By decreasing pro-
inflammatory cytokines release (IFN-ϒ) [74]. IGFs show binding with the insulin 
receptor (IR), insulin-related receptor, and IGF receptor (IGF-1 and IGF-2). Main 
functions of IGF-I and II are mediated by Insulin Growth Factor Insulin receptor 
(IGF-IR) [75]. IGF-I is an important growth factor produced by the macrophages, 
fibroblast keratinocyte, and platelets. It enhances endothelial cell migration into 
the wound site. It enhances the mitosis and fibroblast cell proliferation for the new 
blood vessel formation and extracellular matrix and activation of protein kinase B 
signaling. In addition to this, it also enhances the synthesis of protein and blocks the 
muscles atrophy in order to skeletal hypertrophy catalysis [76].
Upon binding with receptor, the IGF-I activates the insulin receptor substrate-1 
(IRS-1) which in turn by phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K) 
phosphorylates the protein kinase B (Akt). Phosphorylated Akt activates the 
mTOR; PI3K-related kinase controls the proliferation of the cells [77]. Also, IGF-I 
enhances cell growth by activating the mitogen-activated protein kinase/extra-
cellular signal regulated kinase/MAPK/ERK pathway through RAF/RAS kinase 
phosphorylation of [78]. Along with this, IGF-I binding of receptor enhances the 
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secretion of anti-inflammatory cytokine such as IL-10 activates Akt by AMPK 
signaling. Likewise, such as IL-4 and IL-10 can also bind with Akt and plays role in 
M2 macrophages infiltration at the site of wound (Figure 4).
2.1.5  The anti-inflammatory action of insulin through a reduction in pro-
inflammatory cytokine expression enhances the formation of anti-
inflammatory cytokines
The decrease in action of insulin may be due to resistance of insulin or due to 
the insufficient insulin release, and it ultimately results in diabetes mellitus. The 
functioning of insulin either reduces due to the β-cells functioning loss or due to 
the improper functioning of insulin receptors or due to the kidney disease [79]. The 
insulin treatment systemically is already taken by 6 million people of America, and 
it keeps on increasing to control high blood glucose condition. High blood glucose 
concentration leads to the tissue damage by the oxidative stress through increasing 
flux of other sugars and glucose by the polyol pathway and also enhances the expres-
sion end products of advanced glycation and it’s activating ligand receptors and 
through the overexpression of the pathway of hexosamine and activation of protein 
kinase. The mechanisms mainly take place by the overexpression of mitochondrial 
ROS [80]. In the polyol pathway, due to more NADPH consumption in the glucose 
transport pathway, more redox stress is generated and remains insufficient to form 
the scavengers of ROS that is GSH reduced form advanced glycinated product pre-
cursor formation modifies the proteins of plasma that can bind with the receptors 
of the advanced glycination product present on the surface of macrophages, smooth 
cells and vascular endothelial cells. This activation of NFkβ transcription factor, 
in turns activates HIF-ɑ and results in hypoxia stimulated chemokines production 
through the ROS production [81]. In the presence of high glucose, the protein kinase 
enzyme shows hyperactivity and stimulates the expression of eNOS in the smooth 
muscles cells and leads to the destruction of tissue. Increased ROS expression shows 
the activation of different proinflammation pathways and helps in generating the 
epigenetic changes, which can result in the prolonged expression of the proinflam-
matory genes during the wound recovery. Matrix metalloproteinase (MMP-2, 4) 
excessive production impairs the recovery process of wound and results in extracel-
lular matrix protein breakdown such as vitronectin and fibronectin [82].
In nondiabetic wounds, the wound healing process involves the activation of 
the series of different physiological events for wound recovery like inflammation at 
wound site, cell proliferation, epithelisation of cells, vascularisation, maturation, 
and re-modeling at the site of wound [83]. Macrophages play an important role in 
the whole healing process. At early wound phase, in the wound recovery process, 
macrophages function by the cytokine release and activation of leucocytes, which 
leads to the production of inflammatory response at the site of the wound [84].
The infiltration of the macrophage at the wound site takes place by the effect of 
chemotaxis which induces the factors like Toll-like receptor (TLR) ligand, PAMP 
(pathogen-associated molecular patterns), LPS (lipopolysaccharide), PDGF, and 
IFN-gamma (IFN-ϒ) [85]. M1 macrophages lead to high level secretion of STAT1 
and expression of TNF-α or IFN-β. By the activation of the Akt/PI3 pathway, insulin 
stimulates STAT3, which inhibits STAT1 formation and activates the transition from 
M1 macrophages to M2 macrophages for the repairing of wound and tissue repair-
ing. M2 macrophages can help in the production of polyamines and ornithine by the 
pathway of arginase enzyme and anti-inflammatory pathway IL-10, IL-13and IL-4 
cytokines [86]. Insulin along with M2 macrophages activates the anti-inflammatory 
cytokines by Akt, or IP3K pathway activates biosynthesis of protein to induce fatty 
acid and blood vessel formation and division and migration of cells, to increase 
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wound recovery. With resistance of insulin in diabetic condition, there is constant 
increase in concentration of proinflammatory cytokines TNFα and IL-6 have been 
shown in the figure. In the non-diabetic/normal glycemic condition, cytokines 
are produced by adipocytes such as IL-13, which can promote the M2 activa-
tion or alternative macrophages. Alternatively, M2 or activated macrophages are 
important for the expression of anti-inflammatory cytokine secretion such as IL-10 
and PPAR-ϒ (Peroxisome Proliferator-Activated Receptor Gamma) and insulin-
sensitizing factors, forming a vicious circle for the functionality of insulin. PPAR-ϒ 
also activates anti-inflammatory IL-10 cytokine [87] (Figure 4).
In the glycemic condition, there is an excessive proinflammatory macrophage 
expression of cytokines like TNF-α and IL-1β leading to impaired wound recovery. 
Overactivation of cytokines like IL-17, TNF-α or IL-1β reduces expression of inflam-
matory cytokines and upregulates genes responsible for wound healing and increases 
the healing process [86]. In the blood and adipose tissue, the high TNF-α cytokine 
concentration and TNF-α neutralization improve the insulin sensitivity in the 
humans or animals. High glucose condition stimulates changes in the gene expres-
sion and adipocyte metabolism and lipolysis increment and synthesis of fatty acids 
(FFAs) and proinflammatory cytokines induces the expressions of macrophages, like 
tumor necrosis factor α (TNF-α) and monocyte chemotactic protein-1 (MCP-1). M1 
macrophage activation produces an excessive concentration of cytokines responsible 
for inflammation such as TNFα, resistin, and IL-1β, which can act on the cells of 
adipocyte to make them insulin-resistant. This signaling pathway forms the feedback 
loop which can increase the resistance to insulin and inflammation [88].
TNF-α, an inflammatory cytokine, performs role in the healing of nondiabetic 
wound process, but activation of TNF-α for a long time leads to enhancing enzy-
matic activity of protease enzyme. In human diabetic wounds, MMPs are found in 
very high amount. In chronic or diabetic wounds, there is imbalance in the expres-
sion of cytokines causes proinflammation and their proteases, inhibitors, and their 
ant protease expression [89].
The switching of macrophages in the high glucose condition gets delayed due to 
MMPs, IL-1β, IL-6, and ROS cytokine oxidative stress (Figures 5 and 6). This leads 
to delay in M1 to M2 transition and is responsible for the inflammation for long time 
and leads to delay in the wound recovery [90, 91]. The insulin role in the switching 
from inflammatory state to anti-inflammatory state is shown in Figure 5.
2.1.6 The insulin-like activity of C -peptide
C-peptide consists of only 31 amino acids, is a short peptide and has glycine 
amino acid-rich regions and behaves like a linker between the two peptides 
of proinsulin A and B [93]. By ERK1/2 activation and Akt phosphorylation, 
C-peptide shows angiogenesis. The angiogenesis signaling pathway shows similar-
ity with the VEGF pathway and leads to the formation of nitric oxide by eNOS 
activation. C-peptide plays a curious role in the cell mitogenesis like insulin, by 
the same signaling pathway as the insulin protein [94]. C-peptide shows binding 
to the insulin receptor (IR) and results in intracellular substrate phosphorylation 
in Ras/MAPK. The PI3K/Akt signaling results in cell division and mitogenesis. 
Along with the abovementioned two functions, C-peptide also shows its anti-
inflammatory effect. C-peptide shows MIP-1ɑ, IL-8, MIP-1β, and IL-6 expression 
inhibition and other pro-inflammatory cytokine expression [95]. Like insulin, 
C-peptide can also reduce the problems linked with diabetes, such as vascular 
inflammation, neuropathy, and nephropathy, in diabetes case especially type 1 
diabetes case [96].
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The C-peptide level rises in the blood during diabetic mellitus type 2, which is 
due to resistance of insulin [97]. At this time, endothelial dysfunction initiated led 
by the C-peptide deposition in the blood vessel intima walls. The C-peptide deposi-
tion causes more inflammation in the blood vessels of the aortic arch and promotes 
atherosclerotic lesions. The inflammation effect of C-peptide is shown due to 
C-peptide chemotactic behaviour towards macrophages responsible for inflamma-
tion. Monocytes/T-lymphocytes/macrophages migrate through the vessel walls and 
then release TNF-ɑ, IL-6, and MIF etc., pro-inflammatory cytokines and chemo-
kines and nitric oxide, and activates intracellular signaling pathway [98].
Figure 5. 
Effect of insulin on switching of M1 to M2 macrophages. In insulin presence, (AMPK, Akt, STAT3, PKC, 
HIF-α, PI3K, NFkβP50/P50, and ERK) M2 macrophage expression increases show an anti-inflammatory 
effect and help in wound healing.
Figure 6. 
TEM micrographs of AgNPs and IAgNPs shown with insulin protein coating; the size of AgNPs shifts from 
around 22 ± 2 to 1.96 ± 0.1 nm. Scale bar: 50 nm [40].
Wound Healing
12
3. Insulin encapsulated mettalic nanoformulations for wound recovery
Nanoparticles of metals such as silver nanoparticles can be used for the delivery 
of insulin at the site of a wound. Silver nanoparticles have clinical applications due 
to its antibacterial, anti-inflammatory, and wound healing role. Due to the presence 
of charge on the surface of metal nanoparticle surface, they are highly reactive and 
can be surfaces modified by adsorbing different molecules or drugs. The drugs 
having thiol or amine can easily adsorb on the surface of silver nanoparticles, and 
due to this, it can help as a drug delivery agent. The anti-inflammatory effect and 
wound healing (non-diabetic and diabetic) efficiency of silver nanoparticles can be 
improved by encapsulating the insulin with silver nanoparticles [99, 100].
3.1 Synthesis and characterization of metal insulin nanoparticles
It is very easy to synthesize silver nanoparticles by using reducing and stabiliz-
ing agents. Plant extracts like tulsi leaf extract may be used as both reducing and 
stabilizing agents. The tulsi (Ocimum tenuiflorum) aqueous extract of leaves (ATE) 
was extracted by boiling 3 g of tulsi leaves in water (100 ml for 2 h). After extrac-
tion, the extract was allowed to cool and filtered, and the pH of the extract was 
adjusted to 7.4, and the pH adjusted extract was stored at 4°C for further use. AgNP 
synthesis was performed by using ATE as a reducing and capping agent. AgNO3 
240 μM was added in ATE (5000 μl) and for 10 min was kept under sunlight. The 
solution color changed from faint light yellow to reddish brown in the presence of 
sunlight. After this, AgNPs were incubated with insulin at physiological conditions, 
the temperature being 37°C for an hour in an incubator in order to produce insulin-
protected AgNPs (IAgNPs).
Surface plasmon of nanoparticles with or without protein was monitored using 
a UV–visible spectrophotometer equipped with Peltier, which showed a resonance 
peak observed at 352 nm due to the silver nitrate reduction by ATE in sunlight. 
After incubation with insulin, a blue shift (3 nm) with almost peak intensity double 
was observed, and λmax was obtained at 349 nm due to the formation of mono-
dispersed IAgNPs. The hydrodynamic size of 22 ± 2 and 42 ± 2 nm (approximately 
diameter) are observed for AgNPs and IAgNPs, respectively. The Zeta potential 
showed an increment in the potential values from −12.4 to −15.1 mV due to the 
conversion of AgNPs to IAgNPs. TEM micrographs showed that both AgNPs and 
IAgNPs are similar in shape (spherical in shape). AgNP have a size ranging between 
20 ± 4 nm, and further, it received a cap of 2 ± 0.5 nm when coated with insulin 
(IAgNPs) as shown in Figure 6.
3.2  Metallic insulin nanoformulation wound healing and anti-inflammatory 
effect
Wound recovery is promoted by both insulin and IAgNPs in hyperglycemic/dia-
betic and normal/nondiabetic animal conditions. In both in vivo and in vitro cases, 
the insulin promotes the wound healing in hyperglycemic and normal conditions. 
With IAgNPs 12 and 20%, faster wound recovery on treatment’s 5th day of the 
wound was found for nondiabetic and diabetic rats in comparison to the untreated 
control. Whereas in relation to the IAgNPs, faster wound recovery was shown by 
free insulin with lesser efficiency with an enhanced rate of 7.27 and 4.67%, respec-
tively, for the normoglycemic and diabetic rate in comparison to untreated rats. The 
% was 60.0 and 73.33% and with IAgNPs and 33.33 and 40% with only insulin in 
nondiabetic and diabetic models, respectively, on the 11th day, in comparison to the 
untreated controls as shown in Figure 7.
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The quantification of serum showed an increase in anti-inflammatory cytokine 
percentage and reduction in the expression of inflammatory cytokines in diabetic 
and normal/normoglycemic animals after treatment with insulin and IAgNPs 
in comparison to their respective controls. On 5th day, in diabetic rats, the IL-6 
concentration was 25%, and TNF-α is in double higher concentration than the 
normoglycemic control. With treatment of IAgNPs, 50% inhibition of expression of 
cytokine is much higher than free insulin in both the groups. On the 11th day, IL-6 
expression and TNF-α was 30% and 50%, respectively, in control than in normal 
models, which reduces to 45% in both hyperglycemic and normal animals after 
treatment with free insulin, and with IAgNPs, the inhibition was around 30% in 
TNF-α and 40% in IL-6. In addition to reduction in inflammatory cytokine expres-
sion, the anti-inflammatory cytokine percentage (IL-10) increases after treating 
with free insulin and IAgNPs. On the 5th day, IAgNP-treated rats showed that IL-10 
increased 50% in diabetic rats and 70% in normal and similarly showed increment 
in IL-10 concentration of 30% and 45% in diabetic and normal models, respectively, 
in free insulin-treated groups in comparison to control. On 11th day with IAgNPs 
anti-inflammatory cytokine concentration was increased by 50 and 65% and with 
insulin slightly less in both hyperglycemic and normal animals models, respectively. 
On the 5th and 11th days, the histological evaluations significantly decreased leu-
kocyte infiltration level; faster collagen deposition and fast re-epithelization were 
observed with insulin and IAgNPs in relation with sub-group (Figure 8).
Figure 7. 
Wound healing rate of AgNP, ATE-insulin and IAgNP treatment in both hyperglycemic and normal animals 
on 5th day and 11th day. (A) Wound contraction physical observation in various treatment and control groups. 
(B) Percentage of closure of wound in different treated groups (AgNPs, ATE-insulin, and IAgNPs) and 
respective controls of hyperglycemic and normal animals until complete healing of wound takes place.  
(C) Percentage of contraction of wound in four subgroups of hyperglycemic and normal animals on 5th day. 
(D) Percentage of contraction of wound in all the four subgroups of hyperglycemic and normal animals on the 
11th day [40].
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4. Conclusions
Insulin, a hormone which shows the various multiple functions in the body like 
controlling the inflammation, enhancing the differentiation of cells, biosynthesis of 
protein and lipid, etc., in addition to controlling the level of glucose in blood through 
metabolism of glucose. By the metabolism of glucose, the NFkβP50/P50 and IL-8 get 
activated, causing an inactivation of the IL-1β, TNF-α, NFkβP50/P65, IL-6, resistin 
IFN- ϒ, and NOX pro-inflammatory cytokines. The metabolism of fat by insulin 
through inactivating TNF-ɑ mediated pathway also inactivates the pro-inflammatory 
cytokines. The synthesis of protein gets induced by insulin through Akt; PI3K path-
way helps in survival of the cell through the formation of 4EBPI, ribosomal protein S6 
(rpS6). This indicates that along with maintaining the blood glucose level, the insulin 
also shows its anti-inflammatory effect, though the mechanistic aspects of the insu-
lin’s anti-inflammatory role is still remained to be elucidated and understood. In addi-
tion to biosynthesis and metabolism, insulin pathways have the similarity in structure 
with IGF-I, can also bind with receptor of IGF and can shows anti-inflammatory 
activity through PI3K and Akt signaling pathway, which leads to the activation of the 
Figure 8. 
Histological evaluation (40×) wound site of different groups (a and B, respectively). On the 5th and 11th day 
of post-treatment, infiltration of leukocyte, formation of exudates and deposition of collagen are denoted by 
red, yellow and white arrows respectively. Each micrograph represents an overall pattern of a 6-rats group. 
(C–E). Pro-inflammatory cytokines such as IL-6 and TNF-ɑ and the anti-inflammatory cytokines like IL-10 
concentration in all sub-groups of hyperglycemic/and normal animals at 5th and 11th day. TNF-ɑ and IL-6 
results show a significant reduction and IL-10 increment by IAgNP treatment in comparison to control, AgNPs, 
and ATE-insulin-treated animals of both sets on the 5th and 11th day, respectively. Values are shown by the 
average ± SD of group of six rats [40].
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pro-inflammatory cytokines such as STAT-3 and can activate Akt again and promote 
the formation of blood vessels and increases the eNOS production. Likewise, due to 
similarity in structure, insulin can bind with the receptors of IGF and activate the 
same pathway as GF/IGF-I, necessitating further studies on insulin, IGFs and their 
role in anti- response of inflammation (Figure 5). About 5% of the world population 
is diabetic and are in the risk of nonrecoverable or slow wound recovery. The insulin 
can increase the recovery of wound by inflammatory dynamics modulating, therefore 
insulin-like inflammatory modulators (such as IGF) or insulin novel formulations 
based on and have a huge potential for the different clinical applications such as 
including the diabetic care and should be explored for the beneficiary purposes.
5. Future perspective
Inflammatory regulation is one of the most important factors for wound recovery 
which caught attention lately. Here in this chapter, the authors have discussed the 
role of inflammatory regulators in controlling wound recovery taking insulin as an 
example and model drug for diabetes treatment where wound recovery get delayed to 
prolonged inflammation. Macrophages in the wound tissue play a critical role in con-
trolling the wound recovery process. Macrophage plasticity is curtailed in the initia-
tion of tissue regeneration, tissue remodeling, and epithelization. Anti-inflammatory 
activators which can promote M1 to M2 Macrophage transition have a great influence 
in the promotion of wound recovery. Therefore, anti-inflammatory molecules can be 
of great virtue for designing advanced wound recovery agents in the future.
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